Literature DB >> 18815309

Escape from HLA-B*08-restricted CD8 T cells by hepatitis C virus is associated with fitness costs.

Shadi Salloum1, Cesar Oniangue-Ndza, Christoph Neumann-Haefelin, Laura Hudson, Silvia Giugliano, Marc aus dem Siepen, Jacob Nattermann, Ulrich Spengler, Georg M Lauer, Manfred Wiese, Paul Klenerman, Helen Bright, Norbert Scherbaum, Robert Thimme, Michael Roggendorf, Sergei Viazov, Joerg Timm.   

Abstract

The inherent sequence diversity of the hepatitis C virus (HCV) represents a major hurdle for the adaptive immune system to control viral replication. Mutational escape within targeted CD8 epitopes during acute HCV infection has been well documented and is one possible mechanism for T-cell failure. HLA-B*08 was recently identified as one HLA class I allele associated with spontaneous clearance of HCV replication. Selection of escape mutations in the immunodominant HLA-B*08-restricted epitope HSKKKCDEL(1395-1403) was observed during acute infection. However, little is known about the impact of escape mutations in this epitope on viral replication capacity. Their previously reported reversion back toward the consensus residue in patients who do not possess the B*08 allele suggests that the consensus sequence in this epitope is advantageous for viral replication in the absence of immune pressure. The aim of this study was to determine the impact of mutational escape from this immunodominant epitope on viral replication. We analyzed it with a patient cohort with chronic HCV genotype 1b infection and in a single-source outbreak (genotype 1b). Sequence changes in this highly conserved region are rare and selected almost exclusively in the presence of the HLA-B*08 allele. When tested in the subgenomic replicon (Con1), the observed mutations reduce viral replication compared with the prototype sequence. The results provide direct evidence that escape mutations in this epitope are associated with fitness costs and that the antiviral effect of HLA-B*08-restricted T cells is sufficiently strong to force the virus to adopt a relatively unfavorable sequence.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18815309      PMCID: PMC2583685          DOI: 10.1128/JVI.00997-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C.

Authors:  Andrea L Cox; Timothy Mosbruger; Georg M Lauer; Drew Pardoll; David L Thomas; Stuart C Ray
Journal:  Hepatology       Date:  2005-07       Impact factor: 17.425

Review 2.  Rates of spontaneous mutation.

Authors:  J W Drake; B Charlesworth; D Charlesworth; J F Crow
Journal:  Genetics       Date:  1998-04       Impact factor: 4.562

3.  De novo generation of escape variant-specific CD8+ T-cell responses following cytotoxic T-lymphocyte escape in chronic human immunodeficiency virus type 1 infection.

Authors:  Todd M Allen; Xu G Yu; Elizabeth T Kalife; Laura L Reyor; Mathias Lichterfeld; Mina John; Michael Cheng; Rachel L Allgaier; Stanley Mui; Nicole Frahm; Galit Alter; Nancy V Brown; Mary N Johnston; Eric S Rosenberg; Simon A Mallal; Christian Brander; Bruce D Walker; Marcus Altfeld
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

4.  Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in germany: a 20-year multicenter study.

Authors:  M Wiese; F Berr; M Lafrenz; H Porst; U Oesen
Journal:  Hepatology       Date:  2000-07       Impact factor: 17.425

5.  Relative replication capacity and selective advantage profiles of protease inhibitor-resistant hepatitis C virus (HCV) NS3 protease mutants in the HCV genotype 1b replicon system.

Authors:  Yupeng He; Martin S King; Dale J Kempf; Liangjun Lu; Hock Ben Lim; Preethi Krishnan; Warren Kati; Timothy Middleton; Akhteruzzaman Molla
Journal:  Antimicrob Agents Chemother       Date:  2007-12-17       Impact factor: 5.191

6.  Divergent and convergent evolution after a common-source outbreak of hepatitis C virus.

Authors:  Stuart C Ray; Liam Fanning; Xiao-Hong Wang; Dale M Netski; Elizabeth Kenny-Walsh; David L Thomas
Journal:  J Exp Med       Date:  2005-06-06       Impact factor: 14.307

7.  CD8 epitope escape and reversion in acute HCV infection.

Authors:  Joerg Timm; Georg M Lauer; Daniel G Kavanagh; Isabelle Sheridan; Arthur Y Kim; Michaela Lucas; Thillagavathie Pillay; Kei Ouchi; Laura L Reyor; Julian Schulze zur Wiesch; Rajesh T Gandhi; Raymond T Chung; Nina Bhardwaj; Paul Klenerman; Bruce D Walker; Todd M Allen
Journal:  J Exp Med       Date:  2004-12-20       Impact factor: 14.307

8.  Immune evasion versus recovery after acute hepatitis C virus infection from a shared source.

Authors:  Ian Tester; Susan Smyk-Pearson; Ping Wang; Anne Wertheimer; Ermei Yao; David M Lewinsohn; John E Tavis; Hugo R Rosen
Journal:  J Exp Med       Date:  2005-06-06       Impact factor: 14.307

9.  Cellular immune selection with hepatitis C virus persistence in humans.

Authors:  Andrea L Cox; Timothy Mosbruger; Qing Mao; Zhi Liu; Xiao-Hong Wang; Hung-Chih Yang; John Sidney; Alessandro Sette; Drew Pardoll; David L Thomas; Stuart C Ray
Journal:  J Exp Med       Date:  2005-06-06       Impact factor: 14.307

10.  Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication.

Authors:  Arne Schneidewind; Mark A Brockman; Ruifeng Yang; Rahma I Adam; Bin Li; Sylvie Le Gall; Charles R Rinaldo; Sharon L Craggs; Rachel L Allgaier; Karen A Power; Thomas Kuntzen; Chang-Shung Tung; Montiago X LaBute; Sandra M Mueller; Thomas Harrer; Andrew J McMichael; Philip J R Goulder; Christopher Aiken; Christian Brander; Anthony D Kelleher; Todd M Allen
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

View more
  25 in total

1.  Human leukocyte antigen B27 selects for rare escape mutations that significantly impair hepatitis C virus replication and require compensatory mutations.

Authors:  Christoph Neumann-Haefelin; Cesar Oniangue-Ndza; Thomas Kuntzen; Julia Schmidt; Katja Nitschke; John Sidney; Célia Caillet-Saguy; Marco Binder; Nadine Kersting; Michael W Kemper; Karen A Power; Susan Ingber; Laura L Reyor; Kelsey Hills-Evans; Arthur Y Kim; Georg M Lauer; Volker Lohmann; Alessandro Sette; Matthew R Henn; Stéphane Bressanelli; Robert Thimme; Todd M Allen
Journal:  Hepatology       Date:  2011-10       Impact factor: 17.425

Review 2.  Adaptive immunity to the hepatitis C virus.

Authors:  Christopher M Walker
Journal:  Adv Virus Res       Date:  2010       Impact factor: 9.937

3.  Immunogenicity and cross-reactivity of a representative ancestral sequence in hepatitis C virus infection.

Authors:  Kelly P Burke; Supriya Munshaw; William O Osburn; Jordana Levine; Lin Liu; John Sidney; Alessandro Sette; Stuart C Ray; Andrea L Cox
Journal:  J Immunol       Date:  2012-04-16       Impact factor: 5.422

4.  Acceleration of hepatitis C virus envelope evolution in humans is consistent with progressive humoral immune selection during the transition from acute to chronic infection.

Authors:  Lin Liu; Brian E Fisher; Kimberly A Dowd; Jacquie Astemborski; Andrea L Cox; Stuart C Ray
Journal:  J Virol       Date:  2010-03-03       Impact factor: 5.103

5.  Transmission of clonal hepatitis C virus genomes reveals the dominant but transitory role of CD8⁺ T cells in early viral evolution.

Authors:  Benoît Callendret; Jens Bukh; Heather B Eccleston; Ryan Heksch; Dana L Hasselschwert; Robert H Purcell; Austin L Hughes; Christopher M Walker
Journal:  J Virol       Date:  2011-09-07       Impact factor: 5.103

6.  Effect of immune pressure on hepatitis C virus evolution: insights from a single-source outbreak.

Authors:  Shahzma Merani; Danijela Petrovic; Ian James; Abha Chopra; Don Cooper; Elizabeth Freitas; Andri Rauch; Julia di Iulio; Mina John; Michaela Lucas; Karen Fitzmaurice; Susan McKiernan; Suzanne Norris; Dermot Kelleher; Paul Klenerman; Silvana Gaudieri
Journal:  Hepatology       Date:  2011-01-18       Impact factor: 17.425

7.  Conflicting selection pressures target the NS3 protein in hepatitis C virus genotypes 1a and 1b.

Authors:  Stephanie Jiménez Irausquin; Austin L Hughes
Journal:  Virus Res       Date:  2009-11-06       Impact factor: 3.303

8.  Compensatory mutations restore the replication defects caused by cytotoxic T lymphocyte escape mutations in hepatitis C virus polymerase.

Authors:  Cesar Oniangue-Ndza; Thomas Kuntzen; Michael Kemper; Andrew Berical; Yaoyu E Wang; Christoph Neumann-Haefelin; Peter Kristian Foote; Kelsey Hills-Evans; Laura L Reyor; Katherine Kane; Adrianne D Gladden; Allyson K Bloom; Karen A Power; Robert Thimme; Georg M Lauer; Matthew R Henn; Arthur Y Kim; Todd M Allen
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

9.  Escape from a dominant HLA-B*15-restricted CD8+ T cell response against hepatitis C virus requires compensatory mutations outside the epitope.

Authors:  Marianne Ruhl; Patrick Chhatwal; Heiko Strathmann; Thomas Kuntzen; Dorothea Bankwitz; Kathrin Skibbe; Andreas Walker; Falko M Heinemann; Peter A Horn; Todd M Allen; Daniel Hoffmann; Thomas Pietschmann; Jörg Timm
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

10.  Loss of viral fitness and cross-recognition by CD8+ T cells limit HCV escape from a protective HLA-B27-restricted human immune response.

Authors:  Eva Dazert; Christoph Neumann-Haefelin; Stéphane Bressanelli; Karen Fitzmaurice; Julia Kort; Jörg Timm; Susan McKiernan; Dermot Kelleher; Norbert Gruener; John E Tavis; Hugo R Rosen; Jaqueline Shaw; Paul Bowness; Hubert E Blum; Paul Klenerman; Ralf Bartenschlager; Robert Thimme
Journal:  J Clin Invest       Date:  2009-01-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.